Division of Immunology, Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
J Allergy Clin Immunol. 2011 Sep;128(3):601-9.e1-4. doi: 10.1016/j.jaci.2011.04.052. Epub 2011 Jul 7.
B cells receive activating signals from T cells through CD40, from microbial DNA through Toll-like receptor (TLR) 9, and from dendritic cells through transmembrane activator and calcium-modulating cyclophilin ligand interactor (TACI). TLR9 and CD40 ligation augment TACI-driven B-cell activation, but only the mechanism of synergy between CD40 and TACI has been explored. Synergy between CD40 and TLR9 in B-cell activation is controversial.
We sought to examine the mechanisms by which TLR9 modulates CD40- and TACI-mediated activation of B cells and to determine whether all 3 receptors synergize to activate B cells.
Naive murine B cells and human PBMCs were stimulated with combinations of anti-CD40, CpG, and a proliferation inducing ligand in the presence of IL-4. Proliferation was measured by means of tritiated thymidine incorporation. Immunoglobulin production was measured by means of ELISA. Class-switch recombination (CSR) was examined by measuring mRNA for germline transcripts, activation-induced cytidine deaminase (AICDA), and mature immunoglobulin transcripts. Plasma cell differentiation was examined by using syndecan-1/CD138 staining and mRNA expression of B lymphocyte-induced maturation protein 1 (Blimp-1).
TLR9 synergized with CD40 and TACI in driving CSR and inducing IgG(1) and IgE secretion by naive murine B cells and synergized with TACI in driving B-cell proliferation and plasma cell differentiation. All 3 receptors synergized together in driving murine B-cell proliferation, CSR, plasma cell differentiation, and IgG(1) and IgE secretion. TLR9 synergized with CD40 and TACI in driving IgG secretion in IL-4-stimulated human B cells.
Signals from TLR9, TACI, and CD40 are integrated to promote B-cell activation and differentiation.
B 细胞通过 CD40 从 T 细胞接收激活信号,通过 Toll 样受体(TLR)9 从微生物 DNA 接收激活信号,通过跨膜激活剂和钙调节环孢素配体相互作用(TACI)从树突状细胞接收激活信号。TLR9 和 CD40 的连接增强了 TACI 驱动的 B 细胞激活,但仅探索了 CD40 和 TACI 之间协同作用的机制。TLR9 和 CD40 在 B 细胞激活中的协同作用存在争议。
我们试图研究 TLR9 调节 CD40 和 TACI 介导的 B 细胞激活的机制,并确定这 3 种受体是否协同激活 B 细胞。
在 IL-4 存在的情况下,用抗 CD40、CpG 和增殖诱导配体组合刺激幼稚小鼠 B 细胞和人 PBMC。通过氚标记胸腺嘧啶掺入测量增殖。通过 ELISA 测量免疫球蛋白产生。通过测量种系转录物、激活诱导胞苷脱氨酶(AICDA)和成熟免疫球蛋白转录物来检查类别转换重组(CSR)。通过使用 syndecan-1/CD138 染色和 B 淋巴细胞诱导成熟蛋白 1(Blimp-1)的 mRNA 表达来检查浆细胞分化。
TLR9 与 CD40 和 TACI 协同驱动 CSR,并诱导幼稚小鼠 B 细胞分泌 IgG(1)和 IgE,与 TACI 协同驱动 B 细胞增殖和浆细胞分化。这 3 种受体协同作用共同驱动小鼠 B 细胞增殖、CSR、浆细胞分化和 IgG(1)和 IgE 分泌。TLR9 与 CD40 和 TACI 协同驱动 IL-4 刺激的人 B 细胞中 IgG 的分泌。
TLR9、TACI 和 CD40 的信号被整合以促进 B 细胞的激活和分化。